Trial NCT04261439

View at ClinicalTrials.gov 
Org. Study IDs: CNIZ985B12101
Secondary IDs: 2019-004069-42

Last trial update was posted on 2024-01-16

MeSH Interventions

Spartalizumab Tislelizumab

MeSH Conditions

Lymphoma Melanoma

Other Conditions

In Escalation: All Patients With Solid Tumors and Lymphoma In Expansion: Melanoma, Non-small Cell Lung Cancer

Stopping Reasons

Business decision and not due to any safety concerns

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID